235 related articles for article (PubMed ID: 26845386)
1. Antibody-Mediated Rejection in Lung Transplantation: Clinical Outcomes and Donor-Specific Antibody Characteristics.
Roux A; Bendib Le Lan I; Holifanjaniaina S; Thomas KA; Hamid AM; Picard C; Grenet D; De Miranda S; Douvry B; Beaumont-Azuar L; Sage E; Devaquet J; Cuquemelle E; Le Guen M; Spreafico R; Suberbielle-Boissel C; Stern M; Parquin F;
Am J Transplant; 2016 Apr; 16(4):1216-28. PubMed ID: 26845386
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation.
Roux A; Bendib Le Lan I; Holifanjaniaina S; Thomas KA; Picard C; Grenet D; De Miranda S; Douvry B; Beaumont-Azuar L; Sage E; Devaquet J; Cuquemelle E; Le Guen M; Suberbielle C; Gautreau C; Stern M; Rossetti M; Hamid AM; Parquin F
Front Med (Lausanne); 2017; 4():155. PubMed ID: 29075627
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
6. Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work?
Vacha M; Chery G; Hulbert A; Byrns J; Benedetti C; Finlen Copeland CA; Gray A; Onwuemene O; Palmer SM; Snyder LD
Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 27988971
[TBL] [Abstract][Full Text] [Related]
7. Impact of active antibody-mediated rejection treatment on donor-specific antibodies in pediatric kidney transplant recipients.
Kincaide E; Hitchman K; Hall R; Yamaguchi I; Ding Y; Crowther B
Pediatr Transplant; 2019 Dec; 23(8):e13590. PubMed ID: 31617318
[TBL] [Abstract][Full Text] [Related]
8. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
9. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.
Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Transpl Int; 2017 Apr; 30(4):347-359. PubMed ID: 27717025
[TBL] [Abstract][Full Text] [Related]
10. Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study.
Cioni M; Nocera A; Tagliamacco A; Basso S; Innocente A; Fontana I; Magnasco A; Trivelli A; Klersy C; Gurrado A; Ramondetta M; Boghen S; Catenacci L; Verrina E; Garibotto G; Ghiggeri GM; Cardillo M; Ginevri F; Comoli P
Transpl Int; 2019 Jan; 32(1):38-48. PubMed ID: 30076765
[TBL] [Abstract][Full Text] [Related]
11. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigens antibodies after lung transplantation: Primary results of the HALT study.
Hachem RR; Kamoun M; Budev MM; Askar M; Ahya VN; Lee JC; Levine DJ; Pollack MS; Dhillon GS; Weill D; Schechtman KB; Leard LE; Golden JA; Baxter-Lowe L; Mohanakumar T; Tyan DB; Yusen RD
Am J Transplant; 2018 Sep; 18(9):2285-2294. PubMed ID: 29687961
[TBL] [Abstract][Full Text] [Related]
13. Durable renal response after combination of bortezomib, corticosteroids, rituximab, and plasmapheresis for late antibody-mediated renal transplant rejection
.
Ding Y; Francis J; Gautam A; Pelletier L; Sanchorawala V; Quillen K
Clin Nephrol; 2018 Apr; 89(4):252-259. PubMed ID: 29208204
[TBL] [Abstract][Full Text] [Related]
14. Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.
Ginevri F; Nocera A; Comoli P; Innocente A; Cioni M; Parodi A; Fontana I; Magnasco A; Nocco A; Tagliamacco A; Sementa A; Ceriolo P; Ghio L; Zecca M; Cardillo M; Garibotto G; Ghiggeri GM; Poli F
Am J Transplant; 2012 Dec; 12(12):3355-62. PubMed ID: 22959074
[TBL] [Abstract][Full Text] [Related]
15. Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients.
Morrow WR; Frazier EA; Mahle WT; Harville TO; Pye SE; Knecht KR; Howard EL; Smith RN; Saylors RL; Garcia X; Jaquiss RD; Woodle ES
Transplantation; 2012 Feb; 93(3):319-24. PubMed ID: 22179403
[TBL] [Abstract][Full Text] [Related]
16. Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation.
Liefeldt L; Brakemeier S; Glander P; Waiser J; Lachmann N; Schönemann C; Zukunft B; Illigens P; Schmidt D; Wu K; Rudolph B; Neumayer HH; Budde K
Am J Transplant; 2012 May; 12(5):1192-8. PubMed ID: 22300538
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients.
Zhang Q; Hickey M; Drogalis-Kim D; Zheng Y; Gjertson D; Cadeiras M; Khuu T; Baas AS; Depasquale EC; Halnon NJ; Perens G; Alejos J; Cruz D; Ali N; Shemin R; Kwon M; Fishbein MC; Ardehali A; Deng M; Reed EF
Transplantation; 2018 Oct; 102(10):e431-e438. PubMed ID: 29916988
[TBL] [Abstract][Full Text] [Related]
18. Circulating B Cells With Memory and Antibody-Secreting Phenotypes Are Detectable in Pediatric Kidney Transplant Recipients Before the Development of Antibody-Mediated Rejection.
Fischman C; Fribourg M; Fabrizio G; Cioni M; Comoli P; Nocera A; Cardillo M; Cantarelli C; Gallon L; Petrosyan A; Da Sacco S; Perin L; Cravedi P
Transplant Direct; 2019 Sep; 5(9):e481. PubMed ID: 31579809
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific Antibodies.
Courtwright AM; Cao S; Wood I; Mallidi HR; Kawasawa J; Moniodis A; Ng J; El-Chemaly S; Goldberg HJ
Ann Am Thorac Soc; 2019 Sep; 16(9):1131-1137. PubMed ID: 31026404
[No Abstract] [Full Text] [Related]
20. The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation.
Aguilar PR; Carpenter D; Ritter J; Yusen RD; Witt CA; Byers DE; Mohanakumar T; Kreisel D; Trulock EP; Hachem RR
Am J Transplant; 2018 Apr; 18(4):936-944. PubMed ID: 28992372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
